Skip to main content
S

SciVision Biotech Inc. — Investor Relations & Filings

Ticker · 1786 TW Manufacturing
Filings indexed 1,662 across all filing types
Latest filing 2026-03-04 Regulatory Filings
Country TW Taiwan
Listing TW 1786

About SciVision Biotech Inc.

https://www.scivision.com.tw

SciVision Biotech Inc. is a specialized developer and manufacturer of advanced medical devices, focusing on the research and production of hyaluronic acid (HA) products. The company leverages its proprietary Crosslinked Hyaluronic Acid Platform (CHAP) technology to create high-performance solutions across multiple medical disciplines. Its core product portfolio includes subcutaneous fillers for facial aesthetics, intra-articular injections for orthopedic joint care, anti-adhesion gels for surgical applications, and vesical instillation solutions for urological treatments. By integrating specialized R&D capabilities with precision manufacturing, SciVision Biotech provides medical-grade HA applications designed to improve patient outcomes in aesthetics and therapeutic recovery. The company is committed to scientific innovation and the expansion of its patented technology to meet diverse clinical needs in the global healthcare market.

Recent filings

Filing Released Lang Actions
115年02月內部人持股異動(事後)
Regulatory Filings
2026-03-04 Chinese
公告本公司114年第四季財務報告董事會預計召開日期為115年 03月06日
Regulatory Filings
2026-02-26 Chinese
115年1月背書保證與資金貸與
Regulatory Filings
2026-02-06 Chinese
115年1月營業收入
Regulatory Filings
2026-02-06 Chinese
115年01月內部人持股異動(事後)
Regulatory Filings
2026-02-05 Chinese
115年01月董事會成員及持股
Regulatory Filings
2026-02-05 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.